BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32194667)

  • 1. Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer.
    Inoue S; Tsunoda T; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Pastan I; Kasugai K; Kasai K; Ikeda H; Inaguma S
    Oncol Lett; 2020 Mar; 19(3):1741-1750. PubMed ID: 32194667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.
    Inaguma S; Wang Z; Lasota J; Onda M; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Ikeda H; Schrump DS; Hassan R; Pastan I; Miettinen M
    Oncotarget; 2017 Apr; 8(16):26744-26754. PubMed ID: 28460459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC).
    Le K; Wang J; Zhang T; Guo Y; Chang H; Wang S; Zhu B
    Int J Med Sci; 2020; 17(4):422-427. PubMed ID: 32174772
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays.
    Shiraishi T; Shinto E; Nearchou IP; Tsuda H; Kajiwara Y; Einama T; Caie PD; Kishi Y; Ueno H
    Virchows Arch; 2020 Sep; 477(3):409-420. PubMed ID: 32107600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma.
    Chu GJ; Linton A; Kao S; Klebe S; Adelstein S; Yeo D; Rasko JEJ; Cooper WA
    Histopathology; 2023 Aug; 83(2):202-210. PubMed ID: 37040900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis.
    Shiraishi T; Shinto E; Yamadera M; Nagata K; Tsuda H; Mochizuki S; Kajiwara Y; Okamoto K; Einama T; Kishi Y; Ueno H
    Oncotarget; 2020 Oct; 11(43):3807-3817. PubMed ID: 33196692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.
    Takamizawa S; Yazaki S; Kojima Y; Yoshida H; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Yonemori K
    BMC Cancer; 2022 Nov; 22(1):1215. PubMed ID: 36434635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors.
    Weidemann S; Gagelmann P; Gorbokon N; Lennartz M; Menz A; Luebke AM; Kluth M; Hube-Magg C; Blessin NC; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Izbicki JR; Jansen K; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech RH; Dum D; Krech T; Marx AH; Simon R
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer.
    Shiraishi T; Shinto E; Mochizuki S; Tsuda H; Kajiwara Y; Okamoto K; Einama T; Hase K; Ueno H
    Virchows Arch; 2019 Mar; 474(3):297-307. PubMed ID: 30603773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelin Expression is Correlated with Chemoresistance in Stage IV Colorectal Cancer.
    Nagata K; Shinto E; Shiraishi T; Yamadera M; Kajiwara Y; Mochizuki S; Okamoto K; Einama T; Kishi Y; Ueno H
    Ann Surg Oncol; 2021 Dec; 28(13):8579-8586. PubMed ID: 34318385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c
    Magalhaes I; Fernebro J; Abd Own S; Glaessgen D; Corvigno S; Remberger M; Mattsson J; Dahlstrand H
    Adv Ther; 2020 Dec; 37(12):5023-5031. PubMed ID: 33052561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
    Kitadai R; Nishikawa T; Yoshida H; Mizoguchi C; Yamamoto K; Kato T; Yonemori K
    J Gynecol Oncol; 2024 Mar; 35(2):e11. PubMed ID: 37914528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a
    Hou X; Wang F; Meng X; Li D; Ding J; Chen Y; Wang Z; Zhu H; Yang Z
    Mol Pharm; 2022 Oct; 19(10):3623-3631. PubMed ID: 35904514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.
    Lamberts LE; de Groot DJ; Bense RD; de Vries EG; Fehrmann RS
    Oncotarget; 2015 Sep; 6(29):28164-72. PubMed ID: 26172299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpatient variability in mesothelin expression necessitates its evaluation before gastric cancer immunotherapy.
    Sotoudeh M; Mansouri V; Shakeri R; Sharififard B; Sajadi N; Naderi M
    Immunotherapy; 2022 May; 14(7):531-538. PubMed ID: 35321580
    [No Abstract]   [Full Text] [Related]  

  • 16. Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma.
    Yeo D; Castelletti L; van Zandwijk N; Rasko JEJ
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment.
    Zhang X; Yu Y; Peer CJ; Landsman R; Skorupan N; Cao L; Alewine C
    Transl Oncol; 2022 Jul; 21():101440. PubMed ID: 35523008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro.
    Miyazawa M; Iwahashi M; Ojima T; Katsuda M; Nakamura M; Nakamori M; Ueda K; Naka T; Hayata K; Iida T; Yamaue H
    Cancer Lett; 2011 Jun; 305(1):32-9. PubMed ID: 21397388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effect of a Mesothelin-Targeted
    Wickstroem K; Hagemann UB; Cruciani V; Wengner AM; Kristian A; Ellingsen C; Siemeister G; Bjerke RM; Karlsson J; Ryan OB; Linden L; Mumberg D; Ziegelbauer K; Cuthbertson AS
    J Nucl Med; 2019 Sep; 60(9):1293-1300. PubMed ID: 30850485
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.